Gregory Gerdeman, PhD

Greg Gerdeman, PhD
Share This
Facebooktwitter

Greg Gerdeman, Ph.D.
Assistant Professor of Biology
Eckerd College
St Petersburg, Florida

Dr. Greg Gerdeman is a neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS). His Ph.D. dissertation in Pharmacology from Vanderbilt University was one of the first studies to discover endocannabinoids acting as “retrograde messengers” that regulate synaptic plasticity in the brain, findings that have become a foundation to modern understanding of the ECS and the neuroprotective actions of cannabis. Dr. Gerdeman’s research has been widely cited in the scientific literature, and highlighted in such diverse publications as Science, National Geographic, Men’s Health, and The New York Times. He has been a member of the International Cannabinoid Research Society (ICRS) since 1999, and his research has been funded by grants from the National Institute on Drug Abuse (NIDA) and the National Science Foundation (NSF).

Dr. Gerdeman is a tenured Assistant Professor of Biology at Eckerd College in St. Petersburg, Florida, where he teaches courses in cell biology, molecular physiology, pharmacology and neuroscience; and directs a research program that investigates the evolution and physiological roles of cannabinoid receptors. He is also Chief Scientific Officer for 3 Boys Farm: a rainwater harvesting, solar powered, low carbon footprint, USDA certified organic produce farm that intends to cultivate medicinal cannabis in the state of Florida.
Eckerd College (link to my faculty bio)
3 Boys Farm

Share This
Facebooktwitter

Mary Lynn Mathre, RN, MSN, CARN

Share This
Facebooktwitter

President, Founding Director

Mary Lynn (ML) Mathre is the President and Co-founder of Patients Out of Time and Past President and Founding Member of the American Cannabis Nurses Association (ACNA). Mary Lynn graduated from the College of St. Teresa In Winona, MN in 1975 and began her nursing career in the U.S. Navy Nurse Corps. She earned her MS degree from Case Western Reserve University in 1985 and her thesis was on Marijuana Disclosure to Health Care Professionals. Originally a medical–surgical nurse, Ms. Mathre changed specialties in 1987 and has been a certified addictions registered nurse (CARN) since 1989. She began as the charge nurse on the Addiction Treatment Unit at the University of Virginia Health System, and later as the first Clinician 5 (expert level), she was the Addictions Consult Nurse for UVA Health System until 2002. She later was Exec. Dir. of an opioid dependence treatment center in Charlottesville.

She is the editor of Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana (1997) and co-editor of Women and Cannabis: Medicine, Science and Sociology (2002).  Ms. Mathre served on the planning committee for Patients Out of Time’s national clinical cannabis conference series that began in 2000; has authored numerous papers and chapters on medical cannabis; authored several organizational resolutions supporting medical cannabis; is a co-host on two weekly radio programs on medical cannabis; testified before numerous state legislative committees; and has spoken on the topic of medical cannabis at numerous local, regional, national and international conferences.

Share This
Facebooktwitter

Ethan Russo, MD

Ethan Russo
Share This
Facebooktwitter

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Medical Director of PHYTECS, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system (“ECS”).

Previously, from 2003-2014, he served as Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy.

He graduated from the University of Pennsylvania (Psychology), and the University of Massachusetts Medical School, before residencies in Pediatrics in Phoenix, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula, Montana for 20 years.

He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, in Medicine at the University of Washington, and as visiting professor, Chinese Academy of Sciences.

He is a former president of the International Cannabinoid Research Society and former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author/editor of seven books on cannabis and medicinal herbs, and has also published numerous book chapters, and over fifty articles in neurology, pain management, cannabis, and ethnobotany. He has consulted or lectured on these topics in more than 30 US states and 30 countries.

Share This
Facebooktwitter

Dustin Sulak, DO

Dustin Sulak
Share This
Facebooktwitter

Integr8 Health
Falmouth, Maine

Dr. Dustin Sulak is an integrative medicine physician with an emphasis in osteopathy, energy medicine, mind-body medicine, and medical cannabis. His clinical practice focuses on treating refractory conditions in adults and children with an individualized, health-centered approach. Dr. Sulak is the founder of Integr8 Health, an integrative medicine center with 3 locations in New England that treat over 18,000 patients with medical cannabis, and Healer.com, an education and research portal for medical cannabis patients.

Share This
Facebooktwitter

Corey Barnette

Corey Barnette
Share This
Facebooktwitter

Owner, District Growers and Metropolitan Wellness
Washington, DC

Corey Barnette is the founder and Chief Executive Officer of District Growers, LLC, a full service grower and producer of cannabis, cannabis concentrates and cannabis-infused edible products. Through Mr. Barnette’s leadership the company has become known as one of the most talented growing operations in the industry and one of the only ethnic minority-owned and operated vertically integrated medical cannabis operations in the United States. Having operated dispensaries and patient cultivation operations since 2008, the Corey Barnette has extensive experience designing, securing, operating and maintaining cannabis cultivation and production operations. Between 2008 and 2010, he served as the Director of the non-profit San Diego Medical Collective that featured four separate patient-operated cultivation facilities. In 2010, he founded and briefly served as the Director of Chi Holistic Collective in San Diego that also featured a cultivation facility. He transitioned his role as Executive Director of the San Diego-based operations with each entity operating in a healthy manner serving more than 14,000 patient members to return to the Washington DC area to found his District Growers. During the process, he also purchased ownership of a dispensary in Washington DC which currently boast more than 30 percent of the patients in Washington, DC – despite being one of five.

Prior to focusing on the medical cannabis industry, Mr. Barnette owned and operated businesses in a number of different industries across several states, including but not limited to automotive manufacturing, pharmaceutical testing, sports and entertainment, and transportation industries. For example, Mr. Barnette owned and operated Primary Physicians Research, a clinical trials service provider of drug testing services to large pharmaceutical companies. From 2001 to 2004, he served as a Vice President of the Small Enterprise Assistance Funds, an emerging market venture capital firm investing in start-up and early-stage businesses in 28 different emerging market countries. From 1997 to 2000, he serves as an investment banker with NationsBanc Montgomery Securires. Mr. Barnette received an MBA from Duke University’s Fuqua School of Business in 1997 and a BS of Mechanical Engineering from Tennessee Technological Univesity in 1992.

Corey Barnette has shown a particular commitment to bettering the communities around the businesses he operates. He has endowed two scholarships in the names of both his wife and his deceased grandfather. In 2012, he led the founding of Shepherd Star Achievers, a parent-run aftercare program at Shepherd Elementary. From 2010- 2011, he served on the Shepherd Elementary School PTA Executive Board. In 2009, he served on the Board of Directors of Little Genius, a math and science program for young boys. Through his fraternity, he has been an active contributor to the Kappa Scholarship Endowment Fund. Each year since 2004, He donates over $1000 per year to providing turkeys to those in need during Thanksgiving. Finally, he is a proud husband to his wife and father to his ten year old and twelve year old daughters.

Share This
Facebooktwitter

David Bearman, MD

David Bearman, MD
Share This
Facebooktwitter

David Bearman, MD
Practicing Physician
Golita, CA

David Bearman received his M.D. from the University of Washington School of Medicine. He has served at all levels of government including the U.S. Public Health Service, Director of Health Services at San Diego State University, Health Officer and Director Sutter County Health Department and Medical Director/Director of Medical Services for the Santa Barbara Regional Health Authority (now CenCal).

Dr. Bearman has a long career in the field of drug abuse treatment and prevention. He was prominent in the community clinic movement, having started the third Free Clinic in the country in Seattle, then directing the Haight Ashbury Drug Treatment Program, and founded the Isla Vista Medical Clinic. He was Medical Director of Santa Barbara County Methadone Maintenance Clinic, Ventura County Opiate Detox Program, and Zona Seca, an outpatient drug treatment program.

He is a leader in the field ofcannabinoid medicine, a co-founder of the American Academy of Cannabinoid Medicine, on the board of Americans for Safe Access and the Advisory Board for Patients Out of Time. The Wall Street Journal Health Blog named him “Doctor of the Day.”

He has taught courses on the physiology and history of substance use and abuse at UCSF, UCSB, and SDSU, been a consultant to Hoffman LaRoche, NIDA and the National PT A, made numerous professional presentations, consulted widely and has been an expert witness in over 400 civil, criminal, and family court cases. Currently he is Zona Seca’s Medical Consultant and maintains a private practice.

Share This
Facebooktwitter

Tamas Biro, MD, PhD

Tamas Biro
Share This
Facebooktwitter

Tamas Biro, MD, PhD
Professor, Dept. of Immunology
Research Center for Molecular Medicine
Departments of Immunology and Physiology
University of Debrecen
Hungary

Dr. Tamás Bíró is a Full Professor and Chair of the Department of Immunology at the University of Debrecen (Faculty of Medicine, Debrecen, Hungary). He is also Head of the DE-MTA „Lendület” Cellular Physiology Group of the Hungarian Academy of Sciences located at the Department of Physiology (University of Debrecen). Both institutions are members of the Research Center for Molecular Medicine of the University which was awarded by the “Center of Excellence” title by the EU.

Dr. Bíró studied general medicine at University of Debrecen. After receiving his MD degree, he spent two years as a Fogarty fellow at the National Cancer Institute (NIH, USA) where he gained substantial experience in molecular pharmacology and neuroscience. After receiving his PhD degree in “Physiology and Neurobiology”, he worked at the Department of Physiology (University of Debrecen) for 15 years where he established and then chaired the Laboratory for Cellular and Molecular Physiology.

His current research activities chiefly focus on understanding the regulatory role of the endocannabinoid system and the closely related family of the TRP ion channels in the formation and establishment of the complex (physico-chemical, immunological, and regeneration) barrier of the human skin. Moreover, multiple projects of his Labs aim at exploiting the potential of numerous synthetic and plant-derived molecules, targeting the endocannabinoid system and certain TRP channels, in the therapeutic management of various skin diseases. Dr. Bíró is the author of more than 130 in extenso publications in renowned international journals and has been the PI of several Hungarian, international (EU), and industrial grants and contracts.

Share This
Facebooktwitter

Mark Blumenthal

Mark Blumenthal
Share This
Facebooktwitter

Founder & Executive Director
American Botanical Council
Austin, TX

Share This
Facebooktwitter

Paul Bregman, MD

Paul Bregman
Share This
Facebooktwitter

Physician and cannabis patient
Denver, CO

Paul Bregman is a medical doctor, trained in diagnostic radiology with expertise in breast imaging. He practiced radiology between 1983-1995 and was Chief of Breast Imaging at Denver Health Medical Center in Denver, CO 1988-1995. Dr Bregman retired disabled in 1995 due to bipolar illness, type 2, which was shown to be treatment resistant to conventional psychiatric medicines. He entered the field of cannabis medicine in 2007, doing clinical work with 3500 patients( evaluations for possible medical cannabis use), advocacy, and cannabis medicine consulting including expert testimony to the CO legislature, 2009-2011.

He has been a legal cannabis patient since 2007 for chronic low back pain and treatment resistant depression associated with his bipolar, type 2, condition. His treating CO psychiatrist of 25 years approves his cannabis regimen as does his orthopedic physician.

Dr. Bregman had a protracted three year battle 2009-2012, with the Colorado Medical Board over his use of medical cannabis for his medical conditions which ended in an unfavorable decision in 2012. The decision stated that any medical physician, MD, DO, could not have an active medical license and practice medicine while using medical cannabis legally in a treatment setting. Dr. Bregman’s case and subsequent decision was precedent setting policy by the CO medical board.

Paul Bregman is currently a cannabis patient advocate and information resource to the cannabis industry with an “inactive” medical license status. He is a cannabis expert, has a medical degree, a medical cannabis patient and an inquiring mind.

Dr. Paul Bregman is a member of the Society of Cannabis Clinicians, the Cannabis Clinicians Colorado organization and certified by the American Academy of Cannabinoid Medicine.

Share This
Facebooktwitter

Malik Burnett, MD, MBA

Malik Burnett
Share This
Facebooktwitter

Johns Hopkins School of Public Health
Washington, DC

As a resident physician in preventive medicine at the Johns Hopkins School of Public Health, Dr. Malik Burnett works to advance the broader drug policy reform agenda with the goal of shifting US drug policy from framework based on criminal justice to one based on public health. He successfully co-chaired the Initiative 71 campaign, a ballot measure legalizing the possession of cannabis in the Nation’s Capital, garnering the support of 70% of voters as a policy manager at the Drug Policy Alliance’s Office of National Affairs. He continues to work with the local and state governments to advance drug policy reform legislation around the country.

Dr. Burnett is originally from Montego Bay, Jamaica by way of Atlanta, Georgia. As a physician advocate, Dr. Burnett also currently the co-chair of the Criminal Justice Committee for the DC Branch of the NAACP. His passion for drug policy is rooted in eliminating the racial disparities which exist in enforcement practices, in addition to the increasing cost effectiveness of drug policy by focusing on health and human rights based programs.

He attended Duke University for nine years as a student, where he completed a five-year joint M.D. and M.B.A. program Duke’s School of Medicine and the Fuqua School of Business, after completing a Bachelor’s of Science in Psychology. At Duke he was very active advocating on behalf of students and under-served communities and served as a Trustee on the Duke University Board of Trustees.

Share This
Facebooktwitter